What one share of OPKO Health holds
We are a diversified healthcare company that seeks to establish industry-leading positions in large and rapidly growing medical markets. Our pharmaceutical business features NGENLA® (somatrogon-ghla), also referred to as Somatrogon (hGH-CTP), a once-weekly human growth hormone injection.
OPKO Health’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.75 |
|---|---|
| Profit | −$0.09 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.17 |
| Cash and investments | $0.40 |
| Debt | $0.01 |
| Book value | $1.59 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $0.02 | −$0.15 | $0.00 | −$0.10 | — | $0.14 |
| 2010 | $0.11 | −$0.08 | $0.00 | −$0.08 | — | $0.09 |
| 2011 | $0.10 | −$0.01 | $0.01 | −$0.07 | — | $0.54 |
| 2012 | $0.16 | −$0.11 | $0.01 | −$0.09 | — | $0.60 |
| 2013 | $0.27 | −$0.32 | $0.01 | −$0.17 | — | $2.12 |
| 2014 | $0.22 | −$0.41 | $0.01 | −$0.23 | — | $1.95 |
| 2015 | $1.01 | −$0.06 | $0.02 | $0.31 | — | $3.67 |
| 2016 | $2.01 | −$0.10 | $0.03 | $0.02 | — | $3.67 |
| 2017 | $1.73 | −$0.55 | $0.08 | −$0.25 | — | $3.30 |
| 2018 | $1.76 | −$0.27 | $0.05 | −$0.24 | — | $3.06 |
| 2019 | $1.51 | −$0.53 | $0.02 | −$0.31 | — | $2.41 |
| 2020 | $2.24 | $0.05 | $0.05 | $0.01 | — | $2.49 |
| 2021 | $2.74 | −$0.05 | $0.05 | $0.01 | — | $2.47 |
| 2022 | $1.40 | −$0.46 | $0.03 | −$0.17 | — | $2.02 |
| 2023 | $1.15 | −$0.25 | $0.02 | −$0.06 | — | $1.85 |
| 2024 | $1.03 | −$0.08 | $0.04 | −$0.30 | — | $2.03 |
| 2025 | $0.81 | −$0.30 | $0.02 | −$0.25 | — | $1.67 |
Common questions about OPKO Health
How much does one share of OPKO Health earn?
Over the last 12 months, OPKO Health lost $0.09 for each share on $0.75 of sales.
Does OPKO Health pay a dividend?
OPKO Health didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is OPKO Health’s book value per share?
OPKO Health’s book value is $1.59 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of OPKO Health have?
Each share of OPKO Health has $0.40 of cash and investments and $0.01 of debt, as of June 30, 2026.
What is OPKO Health’s free cash flow per share?
−$0.17 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has OPKO Health bought back shares?
OPKO Health’s share count rose about 222% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.